文献速递产科母胎医学

量化胎盘植入谱系疾病严重程度及其相关失血量:一种新型经阴道超声评分系统

Quantifying placenta accreta spectrum severity and its associated blood loss: a novel transvaginal ultrasound scoring system.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-08-05

本研究对73例临床和超声疑似胎盘植入谱系疾病(PAS)患者进行前瞻性数据的二次分析,应用基于经阴道超声的三域半定量评分(0-9分)预测PAS严重程度及失血量。评分0分组100%无术中PAS,评分越高与严重PAS形式相关(r=0.301,P=.02),评分类别2和3与显著更多失血相关。

要点

  • 经阴道超声评分0分者100%无术中PAS,阴性预测值100%。
  • 评分0-3分者阴性预测值97%,仅1例有术中PAS。
  • 评分类别2(β=0.97,P<.01)和类别3(β=1.26,P<.003)失血量显著高于类别0。

核心结论

  • 经阴道超声评分可区分低风险组(类别0)和较高PAS风险组(类别1-3),类别1-3可能为估计严重PAS形式和术中失血风险提供重要临床信息。

研究设计与样本

  • 对一家四级中心前瞻性收集的临床和2D超声疑似PAS患者数据进行二次分析,共评估73例患者。
  • 评分系统基于三个组成部分:子宫壁缺损(0-3分)、子宫壁缺损处动脉血管分布(0-3分)和宫颈受累(0-3分),累积最终评分0-9分。
  • 患者由多学科团队根据患者偏好选择剖宫产伴胎盘取出、剖宫产伴胎盘原位保留(保守)伴或不伴延迟子宫切除术、或剖宫产子宫切除术。
  • 按评分单位记录病理检查不同胎盘侵入程度的频率,采用多元线性回归分析评分与失血量的关联,并校正PAS危险因素。

主要发现

  • 11例评分0分患者均行剖宫产伴胎盘取出,无术中PAS证据,阴性预测值100%。
  • 其余62例评分1-9分;评分0-3分者(n=20)中仅1例有术中PAS,阴性预测值97%。
  • 较高评分与严重PAS形式相关(r=0.301,P=.02)。
  • 中位失血量:类别0=635±352 mL,类别1=634±599 mL,类别2=1549±1284 mL,类别3=1895±2106 mL(P<.001)。
  • 多变量分析中,类别2(β=0.97,P<.01)和类别3(β=1.26,P<.003)与显著高于类别0的失血量相关,与手术类型无关。

关键数值与推荐

  • 子宫壁评分:0分=下段胎盘覆盖处低透亮子宫壁无丢失;1分=丢失<3 cm缺损;2分=3-6 cm缺损;3分=>6 cm缺损。
  • 动脉血管分布评分:0分=未见血管;1分=缺损处1-2根血管;2分=3-5根血管;3分=>5根血管。
  • 宫颈受累评分:0分=宫颈长度正常无前置;1分=前置胎盘伴宫颈长度正常;2分=宫颈短伴前置胎盘、少量血管和小子宫陷窝;3分=宫颈短伴前置胎盘、血管增多和大子宫陷窝。
  • 评分类别:类别0=PAS评分0分;类别1=评分1-3分;类别2=评分4-6分;类别3=评分7-9分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemorrhage associated with placenta accreta spectrum (PAS) is a leading cause of maternal morbidity and mortality. Estimating blood loss in these individuals is a critical component of comprehensive preoperative planning. OBJECTIVE: A semiquantitative score based on transvaginal ultrasound was developed and tested to predict PAS, estimate its severity, and blood loss in individuals with clinical and ultrasound evidence suggesting PAS. STUDY DESIGN: A secondary analysis was conducted of prospectively collected data from a quaternary center of patients with suspected accreta on 2D ultrasound and clinical suspicion. A predetermined scoring system was applied based on three components: (1) uterine wall (score 0: no loss of hypo-translucent uterine wall with overlying placenta in the lower uterine segment; 1: loss of hypo-translucent <3-cm defect; 2: 3-6-cm defect; and 3: >6-cm defect); (2) arterial vascularity at the uterine wall defect (score 0: no vessels observed; 1: 1-2 vessels over the defect; 2: 3-5 vessels; and 3: >5 vessels); and (3) cervical involvement (score 0: normal cervical length without previa; 1: previa with normal cervical length; 2: short cervix with previa, minimal vascularity and small lacunae; 3: short cervix with previa, increased vascularity and large lacunae). Each patient's three domain scores determined a cumulative, final score of 0-9. Patients were managed at the discretion of a multi-disciplinary team and patient's preference among the following options: cesarean delivery with placenta removal, cesarean delivery with placenta in-situ (conservative) with or without delayed hysterectomy, or cesarean hysterectomy. The frequency of different degrees of placental invasion per pathology examination per score unit was registered. Multiple linear regression analysis was performed for association of blood loss according to score adjusted by risk factors for PAS. RESULTS: A total of 73 patients were evaluated. All 11 patients who had a score of 0 had cesarean delivery with placenta removal without evidence of intraoperative PAS, thus resulting in a 100% negative predictive value. The remaining 62 had scores between 1 and 9. Among patients with scores 0-3 (n=20), only one had intraoperative PAS, yielding a negative predictive value of 97%. Higher scores were associated with severe PAS forms (r=0.301, P=.02). Based on the associations between PAS scores, clinical correlation, and blood loss, we divided patients into four categories: Category 0: PAS score 0; Category 1: scores 1-3; Category 2: scores 4-6; and Category 3: scores 7-9. The median blood loss in Category 0=635±352 mL, Category 1=634±599 mL, Category 2=1549±1284 mL, and Category 3=1895±2106 mL (P<.001). On multivariable analysis, Category 2 (β=0.97, P<.01) and Category 3 (β=1.26, P<.003) were associated with significantly greater blood loss than Category 0, irrespective of type of surgery. CONCLUSION: The transvaginal ultrasound score separates groups at low risk (Category 0) and at higher risk of PAS (Categories 1-3). Categories 1-3 may provide important clinical information to estimate the risk of severe forms of PAS and of blood loss during surgery. VIDEO ABSTRACT.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Agarwal N, Hernandez-Andrade E, Sibai BM, et al. Quantifying placenta accreta spectrum severity and its associated blood loss: a novel transvaginal ultrasound scoring system. Am J Obstet Gynecol MFM. 2024. PMID: 39096965. doi:10.1016/j.ajogmf.2024.101451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。